BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
5.47
0.72 (15.16%)
At close: Aug 15, 2025, 3:59 PM
6.07
10.98%
After-hours: Aug 15, 2025, 07:58 PM EDT
BioXcel Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 120K | 168K | 366K | 214K | 1.1M | 582K | 376K | 341K | 457K | 206K | 238K | 137K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 182K | 14K | 832K | 1.17M | 62K | 158K | 792K | 512K | 26K | 9K | 9K | 11K | 84K | 77K | 76K | 76K | 80K | 65K |
Gross Profit | -62K | 168K | -466K | -956K | 1.04M | 424K | -416K | -171K | 431K | 197K | 229K | 126K | -84K | -77K | -76K | -76K | -80K | -65K |
Operating Income | -15.85M | -13.17M | -10.49M | -15.29M | -17.53M | -23.93M | -19.73M | -48.3M | -52.41M | -51.2M | -52.89M | -38.99M | -36.29M | -31.48M | -26.13M | -26.81M | -27.61M | -26.38M |
Interest Income | 230K | 1.05M | 368K | 616K | 671K | 947K | 946K | 1.07M | 1.62M | 2.02M | 1.49M | 823K | 204K | 15K | 12K | 12K | 10K | 10K |
Pretax Income | -19.19M | -7.25M | -10.86M | -13.65M | -8.3M | -26.79M | -22.26M | -50.49M | -53.52M | -52.8M | -54.81M | -41.8M | -37.67M | -31.47M | -26.13M | -26.81M | -27.62M | -26.38M |
Net Income | -19.19M | -7.25M | -10.86M | -13.65M | -8.3M | -26.79M | -22.26M | -50.49M | -53.52M | -51.03M | -58.09M | -44.62M | -39.05M | -31.46M | -26.13M | -26.81M | -27.62M | -26.38M |
Selling & General & Admin | 5.61M | 3.83M | 4.09M | 7.68M | 9.45M | 13.22M | 9.58M | 24.34M | 25.87M | 23.59M | 20.66M | 17.05M | 18.38M | 12.92M | 13.61M | 14.88M | 14.1M | 11.64M |
Research & Development | 10.26M | 4.55M | 5.9M | 5.1M | 8.03M | 11.14M | 9.93M | 19.62M | 26.97M | 27.8M | 32.46M | 22.06M | 17.91M | 18.56M | 12.53M | 11.93M | 13.51M | 14.74M |
Other Expenses | 107K | 4.96M | 32K | 1.55M | 856K | n/a | 22K | 4.16M | n/a | -246K | -480K | 62K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 15.97M | 13.34M | 10.03M | 14.34M | 18.34M | 24.35M | 19.54M | 48.13M | 52.84M | 51.4M | 53.12M | 39.12M | 36.29M | 31.48M | 26.13M | 26.81M | 27.61M | 26.38M |
Interest Expense | 4.22M | 3.99M | 4.03M | 3.79M | 3.7M | 3.61M | 3.44M | 3.25M | 3.26M | 3.37M | 2.92M | 3.7M | 1.59M | 7K | 6K | 11K | 16K | 7K |
Selling & Marketing Expenses | n/a | n/a | 482K | 279K | 305K | -48K | 319K | 2.99M | 4.81M | 2.6M | 1.96M | 2.74M | 6.31M | n/a | 1.38M | n/a | 2.95M | 2M |
Cost & Expenses | 15.97M | 13.34M | 10.86M | 15.51M | 18.4M | 24.51M | 20.1M | 44.48M | 52.87M | 51.4M | 53.13M | 39.13M | 36.29M | 31.48M | 26.13M | 26.81M | 27.61M | 26.38M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.77M | 3.28M | 2.81M | 1.38M | -8K | n/a | 12K | 10K | 10K |
Shares Outstanding (Basic) | 7.84M | 2.54M | 2.54M | 16.7M | 16.7M | 30.87M | 29.45M | 29.27M | 29.19M | 28.62M | 28.07M | 28.02M | 27.99M | 27.98M | 27.98M | 27.97M | 24.96M | 24.52M |
Shares Outstanding (Diluted) | 7.84M | 2.54M | 2.54M | 16.7M | 16.7M | 30.87M | 29.45M | 29.27M | 29.19M | 28.62M | 28.07M | 28.02M | 27.99M | 27.98M | 27.98M | 27.97M | 24.96M | 24.52M |
EPS (Basic) | -2.45 | -2.86 | -4.28 | -0.82 | -0.5 | -0.87 | -0.76 | -1.72 | -1.83 | -1.78 | -2.07 | -1.59 | -1.4 | -1.12 | -0.93 | -0.96 | -1.11 | -1.08 |
EPS (Diluted) | -2.45 | -2.86 | -4.28 | -0.82 | -0.5 | -0.87 | -0.76 | -1.72 | -1.83 | -1.78 | -2.07 | -1.59 | -1.4 | -1.12 | -0.93 | -0.96 | -1.11 | -1.08 |
EBITDA | -15.85M | -6.86M | -6.75M | -9.78M | -4.52M | -23.11M | -18.74M | -47.16M | -50.1M | -49.35M | -51.81M | -38.44M | -36M | -31.4M | -26.05M | -26.76M | -27.53M | -26.31M |
EBIT | -14.96M | -7.25M | -6.83M | -9.86M | -4.6M | -23.18M | -18.82M | -47.23M | -50.26M | -49.43M | -50.79M | -38.52M | -36.21M | -31.46M | -26.12M | -26.81M | -27.6M | -26.37M |
Depreciation & Amortization | 75K | 399K | 77K | 77K | 77K | 78K | 78K | 79K | 153K | 80K | 81K | 85K | 84K | 77K | 76K | 76K | 80K | 65K |